NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for drug resistance


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Perceived parent-pressure causes excessive antibiotic prescription
2009 NOV 29 ... BioMed Central Ltd., Biotechnology Business, Biotechnology Company, Diagnostics, Drug Resistance, Pediatric, Respiratory Tract Infections, Therapy, Treatment.This article ...
Subject: BioMed Central
Price: $3.00
*
Studies from S.H. Cui et al provide new data on drug resistance
2009 NOV 23 ... Republic of China, Antimicrobial Resistance, Antimicrobials, Chemotherapy, Clindamycin, Drug Resistance, Drug Therapy, Staphylococcus Infections, Therapy, Treatment. This article ...
Subject: Drug Resistance
Price: $3.00
*
Studies from Shanghai Jiao Tong University reveal new findings on insulin resistance
2009 NOV 23 ... or other antidiabetic drugs. TCM involves three particular plants, as an antidiabetic drug." "Our present research planned to evaluate the efficacy of TCM on ... Tong University. The researchers concluded: "TCM can ameliorate insulin resistance in type 2 diabetes and it is safe and effective in newly diagnosed diabetic patients." ...
Subject: Insulin Resistance
Price: $3.00
*
Studies from University of London, Imperial College have provided new data on drug resistance
2009 NOV 23 ... Country:United Kingdom, Antibacterial, Antibiotic, Antimicrobial Resistance, Drug Resistance, Endourology, Surgery, Therapy, Treatment, University of London, Imperial College. ...
Subject: Drug Resistance
Price: $3.00
*
Studies from University of Utah have provided new information about ovarian cancer
2009 NOV 23 ... Acid, Biotechnology, Dietary Supplement, Doxorubicin Hydrochloride, Drug Development, Drug Resistance, Drugs, Gynecology, L-Histidine, Micronutrient, Molecular Pharmacology, Molecular ...
Subject: Ovarian Cancer
Price: $3.00
*
Study data from D.W. Hilbert et al provide new insights into Escherichia coli therapy
2009 NOV 23 ... Antimicrobial Resistance, Antimicrobials, Clinical Microbiology, Diagnosis, Diagnostics, Drug Resistance, Enzymes, Escherichia coli, Gynecology, Infectious Diseases, Polymerase, Therapy, ...
Subject: Escherichia coli Therapy
Price: $3.00
*
Study data from University of Paris update understanding of cancer
2009 NOV 23 ... a wide variety of solid tumors. However, following intravenous administration, this drug is rapidly inactivated by enzymatic deamination and displays a short biological ... this bioconjugate (SQgem) self-organized in water as nanoassemblies with considerable resistance to deamination and significantly higher anticancer activity compared with gemcitabine in ...
Subject: Cancer
Price: $3.00
*
Study findings from Monash University broaden understanding of life sciences
2009 NOV 23 ... Keywords: City:Clayton, Country:Australia, Life Sciences, Antimicrobial Resistance, Drug Resistance, Therapy, Treatment, Clostridium, Antibiotic, Antibacterial, Erythromycin, ...
Subject: Life Sciences
Price: $3.00
*
Study findings from University of Louisville provide new insights into drug resistance
2009 NOV 23 ... Country:United States, Ampicillin, Antibacterial, Antibiotic, Antimicrobial Resistance, Drug Resistance, Drugs, Enzymes, Escherichia coli, Lactamase, Pharmaceuticals, Salmonella, Therapy, ...
Subject: Drug Resistance
Price: $3.00
*
Study results from Federal University broaden understanding of thermal science
2009 NOV 24 ... of Thermal Analysis and Calorimetry, "Norfloxacin (NFX) is a synthetic antibacterial drug. The development of extended release tablets improves the patients' comfort and ... in lower discontinuation of the therapy; with consequently decrease in bacterial resistance.""In the present work, the thermal behavior of NFX was investigated using ...
Subject: Thermal Science
Price: $3.00
*
Study results from New England Biolabs, Inc. update understanding of nematode
2009 NOV 23 ... pathway in vertebrates and its importance in several pathogens make UGMs attractive drug targets." "Since the existence of Gal(f) in nematodes has not been ... glf-1. glf-1 mutants rescued by L. major glf, which behave as glf-1 hypomorphs, display resistance to infection by Microbacterium nematophilum, a pathogen of rhabditid nematodes thought ...
Subject: Nematode
View Free
Daily News
Article
Study results from University of Zurich in the area of HIV/AIDS therapy published
2009 NOV 23 ... K101E/H/P and Y181C/I/V) reduced the treatment response at week 24. Most ETV RAMs in drug-naive patients are polymorphisms rather than transmitted RAMs. Uncertainty regarding ... is a novel nonnucleoside reverse transcriptase inhibitor (NNRTI) with reduced cross-resistance to first-generation NNRTIs, which has been primarily studied in randomized clinical ...
Subject: HIV/AIDS Therapy
Price: $3.00
*
Study results from Y. Schiller and colleagues broaden understanding of epilepsy
2009 NOV 23 ... quantify and identify predictive risk factors for seizure relapse and development of drug resistance in patients who achieved long-term (>1 year) antiepileptic drug-induced seizure ...
Subject: Epilepsy
Price: $3.00
*
Study results from Y. Xia et al provide new insights into pancreatic cancer
2009 NOV 23 ... heat shock protein 27 (Hsp27), a small molecular chaperone playing an important role in drug resistance and highly expressed in drug-resistant cancer forms, and thus represents the first small ...
Subject: Pancreatic Cancer
Price: $3.00
*
The Boston Globe names Cubist to Globe 100's Top Places to Work '09
2009 NOV 23 ... Services, Fina, Technology, Antimicrobial Resistance, Cubist Pharmaceuticals, Drug Resistance, Pharmaceutical Business, Pharmaceutical Company, Therapy, Treatment, Cubist ...
Subject: Cubist Pharmaceuticals, Inc.
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... Clinical Research, Clinical Trial Research, Clinical Trials, Drug Development, Drug Resistance, Drug Therapy, Drugs, Enzymes, Lyase, Oncology, Pharmaceuticals, Pre-Trials Research, ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*
Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
2009 NOV 23 ... of blood pressure and has been a broadly pursued but extremely difficult target to drug within the pharmaceutical industry for many years. Within the bloodstream, renin ... in the renin-angiotensin system to induce vascular constriction and increase vascular resistance, correspondingly increasing blood pressure. Suppression of the renin angiotensin system ...
Subject: Vitae Pharmaceuticals, Inc.
Price: $3.00
*
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
2009 NOV 23 ... Cardiology, Cardiovascular, Carotid Stent, Clinical Trial Research, Coronary Disease, Drug Resistance, FDA, Femoral Artery, Heart Attack, Heart Disease, Hypertension, Infarction, Kidney, ...
Subject: VIVA Physicians, Inc.
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... "These interim results are very promising, indicating a potentially new drug to help control this life-threatening disease with acceptable safety and quality of ... only the cancer fighting component of ifosfamide. It is expected to overcome the resistance seen with ifosfamide and cyclophosphamide, two of the most commonly used alkylating ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*
ZIOPHARM Reports Third Quarter Financial Results and Updated Clinical Progress
2009 NOV 23 ... and to conclude enrollment. The company is in dialogue with the U.S. Food and Drug Administration (FDA) on the design and implementation of a registration trial, a study ... only the cancer fighting component of ifosfamide. It is expected to overcome the resistance seen with ifosfamide and cyclophosphamide, two of the most commonly used alkylating ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login